evacetrapib

The study of evacetrapib involved about 400 patients with elevated LDL levels or low HDL levels.

UPDATE: Lilly Study Shows Experimental Drug Boosts Good Cholesterol Jennifer Corbett Dooren 2011

There were 10 groups in the study looking at three doses of evacetrapib alone and in combination with the three most-prescribed statins: Crestor, Lipitor and Zocor.

UPDATE: Lilly Study Shows Experimental Drug Boosts Good Cholesterol Jennifer Corbett Dooren 2011

David Moller , Eli Lilly vice president of endocrine and cardiovascular research and clinical investigation, said the company is planning larger studies of evacetrapib.

UPDATE: Lilly Study Shows Experimental Drug Boosts Good Cholesterol Jennifer Corbett Dooren 2011

A study involving Eli Lilly & Co.'s experimental drug evacetrapib showed it was able to boost good cholesterol levels while lowering the bad kind.

UPDATE: Lilly Study Shows Experimental Drug Boosts Good Cholesterol Jennifer Corbett Dooren 2011

When given with statins, a 100-milligram dose of evacetrapib was able to increase HDL levels by 78.5% to 88.5%.

UPDATE: Lilly Study Shows Experimental Drug Boosts Good Cholesterol Jennifer Corbett Dooren 2011

Dr. Rader, whose research focuses on HDL cholesterol, was asked to discuss the evacetrapib study on behalf of the American Heart Association.

UPDATE: Lilly Study Shows Experimental Drug Boosts Good Cholesterol Jennifer Corbett Dooren 2011

Steve Nissen , one of the Cleveland Clinic doctors involved in the evacetrapib study, said larger studies will be needed to show if CETP inhibitors are able to reduce cardiovascular events such as heart attacks and strokes.

UPDATE: Lilly Study Shows Experimental Drug Boosts Good Cholesterol Jennifer Corbett Dooren 2011

Eli Lilly and Co.'s evacetrapib showed good effects on cholesterol in a mid-stage study of 400 people testing the drug by itself or with other cholesterol-lowering drugs.

KansasCity.com: Front Page 2011